These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29030771)

  • 21. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pragmatism, dynamism and flexibility in research and clinical practice.
    Acharya G
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):345-6. PubMed ID: 25761442
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory turnaround time.
    Valenstein P
    Am J Clin Pathol; 1996 Jun; 105(6):676-88. PubMed ID: 8659441
    [No Abstract]   [Full Text] [Related]  

  • 26. Twenty statistical errors even you can find in biomedical research articles.
    Lang T
    Croat Med J; 2004 Aug; 45(4):361-70. PubMed ID: 15311405
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
    Tanaka M; Tanaka K
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():842-6. PubMed ID: 26480803
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostics of paraneoplastic neurological syndromes.
    Zoccarato M; Gastaldi M; Zuliani L; Biagioli T; Brogi M; Bernardi G; Corsini E; Bazzigaluppi E; Fazio R; Giannotta C; Nobile-Orazio E; Costa G; Iorio R; Evoli A; Mariotto S; Ferrari S; Galloni E; De Riva V; Zardini E; Franciotta D; Giometto B
    Neurol Sci; 2017 Oct; 38(Suppl 2):237-242. PubMed ID: 29030766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers for neurology: Guides and lines.
    Fleming JO; Carlsson CM
    Neurology; 2014 Sep; 83(13):1130-1. PubMed ID: 25150288
    [No Abstract]   [Full Text] [Related]  

  • 30. Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
    Kakalacheva K; Regenass S; Wiesmayr S; Azzi T; Berger C; Dale RC; Brilot F; Münz C; Rostasy K; Nadal D; Lünemann JD
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26907324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Governance and evidence-based laboratory medicine.
    Trenti T; Canali C; Scognamiglio A
    Clin Chem Lab Med; 2006; 44(6):724-32. PubMed ID: 16729861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the promise of probiotics being fulfilled?
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):711. PubMed ID: 32673600
    [No Abstract]   [Full Text] [Related]  

  • 35. Understanding and interpreting guideline recommendations made with insufficient evidence.
    Wilson LM; Robinson KA
    Paediatr Respir Rev; 2015 Jan; 16(1):49-50. PubMed ID: 25263478
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenges of non-commercial multicentre North-South collaborative clinical trials.
    Ravinetto RM; Talisuna A; De Crop M; van Loen H; Menten J; Van Overmeir C; Tinto H; Gonzalez R; Meremikwu M; Nabasuma C; Ngoma GM; Karema C; Adoke Y; Chaponda M; Van Geertruyden JP; D'Alessandro U
    Trop Med Int Health; 2013 Feb; 18(2):237-41. PubMed ID: 23217117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
    Pacini G; Ieronymaki M; Nuti F; Sabatino G; Larregola M; Aharoni R; Papini AM; Rovero P
    J Pept Sci; 2016 Jan; 22(1):52-8. PubMed ID: 26663200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standards, guidelines, and norms.
    Knottnerus JA; Tugwell P
    J Clin Epidemiol; 2011 Apr; 64(4):345-6. PubMed ID: 21334571
    [No Abstract]   [Full Text] [Related]  

  • 39. Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
    Baumann M; Hennes EM; Schanda K; Karenfort M; Kornek B; Seidl R; Diepold K; Lauffer H; Marquardt I; Strautmanis J; Syrbe S; Vieker S; Höftberger R; Reindl M; Rostásy K
    Mult Scler; 2016 Dec; 22(14):1821-1829. PubMed ID: 26869530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology request guidelines: Haematology questioned.
    Moeng K; Mahomed AD; Patel M; Stanfliet RB; King JA; Pillay TS
    S Afr Med J; 2010 May; 100(5):262, 264; author reply 264, 266. PubMed ID: 20460008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.